|
2025
|
P/S
|
Providing scientific information, news, and commentary in the field of pharmaceuticals; Providing... |
|
|
P/S
|
Pharmaceutical preparations. |
|
|
P/S
|
Pharmaceutical preparations for the treatment of auditory, hematological, gastrointestinal, neuro... |
|
|
P/S
|
Live animals |
|
|
P/S
|
Pharmaceutical research services, namely, nucleic acid molecule development and nucleic acid mole... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of ophthalmological diseases and disorders |
|
|
P/S
|
Pharmaceutical preparations for the prevention and treatment of neuromuscular, muscular, musculos... |
|
|
P/S
|
Business administration services, namely, business administration of a program to provide informa... |
|
|
Invention
|
Methods for treating patients with familial hypercholesterolemia.
The present invention provides... |
|
|
Invention
|
Systems and methods for preparing a polypeptide from a mixture.
Embodiments of the present discl... |
|
|
Invention
|
Methods of treatment using a leptin receptor agonist antibody.
Provided herein are therapeutic m... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of auditory and neurological diseases and disorders... |
|
|
Invention
|
Methods of reducing particle formation and compositions formed thereby.
Biopharmaceutical compos... |
|
|
Invention
|
Methods for obtaining antibodies that bind transmembrane proteins and cells that produce the same... |
|
|
Invention
|
Genetically modified mice comprising humanized cellular immune system components with improved di... |
|
|
Invention
|
Taurine supplemented cell culture medium and methods of use.
The specification describes a compo... |
|
|
Invention
|
Fabrication of protein-encapsulating microgels.
Methods for fabricating protein-encapsulating mi... |
|
|
Invention
|
Anti-vegf protein compositions and methods for producing the same.
The present disclosure pertai... |
|
|
P/S
|
Pharmaceutical preparations and substances for the treatment and/or prevention of diseases, namel... |
|
|
Invention
|
Immunoglobulin proteins that bind to npr1 agonists.
The present disclosure provides novel immuno... |
|
|
Invention
|
17ß-hydroxysteroid dehydrogenase type 13 (hsd17b13) irna compositions and methods of use thereof.... |
|
|
P/S
|
Syringes for medical purposes and for injections; Injection device for pharmaceuticals; Injection... |
|
|
Invention
|
Characterization of adeno-associated virus using microchip capillary electrophoresis.
Methods an... |
|
|
Invention
|
Nucleic acids encoding anchor modified antibodies and uses thereof.
Described herein are anchor-... |
|
|
Invention
|
Plunger for auto-injector and related methods of use.
A plunger may include a body extending fro... |
|
|
Invention
|
Plunger for auto-injector and related methods of use. A plunger may include a body extending from... |
|
|
Invention
|
Stable antibody formulation. The present disclosure provides stable pharmaceutical formulations c... |
|
|
Invention
|
Cblb endonuclease variants, compositions, and methods of use.
The present disclosure provides im... |
|
|
P/S
|
Combination drug delivery devices sold full containing pharmaceutical preparations for the treatm... |
|
|
Invention
|
Methods for treating chronic rhinosinusitis without nasal polyps by administering an il-4r antago... |
|
|
Invention
|
Compositions and methods for treating pain in subjects with rheumatoid arthritis.
The present di... |
|
|
Invention
|
Low concentration vegf receptor fusion protein containing formulations. The present invention pro... |
|
|
Invention
|
Methods and systems for characterizing metal interactions in antibody samples.
Provided herein a... |
|
|
Invention
|
Metabolically optimized cell culture.
Improved methods for large scale production of proteins an... |
|
|
Invention
|
Rodent models of disease. Provided herein are genetically modified rodent models of disease, wher... |
|
|
Invention
|
System and method of categorizing public biomedical databases using large language models. A comp... |
|
|
Invention
|
Recombinant rhabdovirus encoding interleukin-12 (il-12). The application relates to a recombinant... |
|
|
Invention
|
Methods for characterizing proteins in serum samples. Described herein are methods for enriching,... |
|
|
Invention
|
Systems and methods for identifying events in supply chain processes.
A method for identifying a... |
|
|
Invention
|
Compositions and methods for the treatment of myeloproliferative neoplasms. Nucleic acids encodin... |
|
|
Invention
|
Pseudo sample for test method validation. Disclosed herein are a pseudo sample configured for val... |
|
|
Invention
|
Pseudo sample for test method validation.
Disclosed herein are a pseudo sample configured for va... |
|
|
Invention
|
Inhibition of hsd17b13 in the treatment of liver disease in patients expressing the pnpla3 i148m ... |
|
|
Invention
|
Masked multispecific antigen-binding molecules with cleavable linkers.
The present disclosure pr... |
|
|
Invention
|
Masked multispecific antigen-binding molecules with cleavable linkers. e.g.e.g.e.g., a tumor asso... |
|
|
Invention
|
Trivalent multispecific binding molecules and methods of use thereof. The present disclosure rela... |
|
|
Invention
|
Systems and methods for performing gait and speech assessment associated with a disease state.
E... |
|
|
Invention
|
17beta-hydroxysteroid dehydrogenase type 13 (hsd17b13) irna compositions and methods of use there... |
|
|
Invention
|
Compositions and methods for treating cytokine release syndrome.
The present invention provides ... |
|
|
Invention
|
Human antibodies to the glucagon receptor.
The present invention provides antibodies that bind t... |
|
|
Invention
|
Myosin 15 promoters and uses thereof.
The disclosure provides polynucleotides containing regions... |
|
|
Invention
|
Humanized il-6 and il-6 receptor.
Mice that comprise a replacement of endogenous mouse IL-6 and/... |
|
2024
|
Invention
|
Il10 agonists and methods of use thereof.
The present disclosure relates to IL10 agonists with i... |
|
|
Invention
|
Il-2 variants with reduced binding to il-2 receptor alpha and uses thereof.
This disclosure rela... |
|
|
Invention
|
Antigen binding molecule formats.
Antigen binding molecules (ABMs) comprising Fab domains in non... |
|
2023
|
Invention
|
Methods of treating metastatic castration-resistant prostate cancer with bispecific anti-psma x a... |
|
|
Invention
|
Vectors and methods for in vivo antibody production.
The invention relates to compositions and m... |
|
|
Invention
|
Identification of tissue-specific extragenic safe harbors for gene therapy approaches.
Compositi... |
|
|
Invention
|
A rodent model of fibrodysplasia ossificans progressiva.
This disclosure relates to a geneticall... |
|
|
Invention
|
Multipartite receptor and signaling complexes.
The present disclosure provides adoptive T cell t... |
|
2022
|
Invention
|
Viral particles retargeted to skeletal muscle.
Provided herein are compositions and methods for ... |
|
|
Invention
|
Methods of treating cancer in immunosuppressed or immunocompromised patients by administering a p... |
